-transparent.png){kind=logo}
Fifteen patients with metastatic renal cell carcinoma were treated with Baker's antifol at a dose schedule of 250 mg/m2 iv for 3 days every 3 weeks. One objective response was seen, and toxicity was minimal. No usefulness of Baker's antifol in the treatment of metastatic renal cell carcinoma was demonstrated.
Related Publications
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
November 1977,
Cancer treatment reports,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
May 1982,
Cancer treatment reports,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
January 1990,
Journal of the National Cancer Institute,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
January 1981,
Cancer treatment reports,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
January 1990,
Investigational new drugs,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
July 1992,
Investigational new drugs,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
November 1991,
Investigational new drugs,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
June 1984,
Cancer treatment reports,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
January 1990,
Investigational new drugs,
R M Bukowski, and
A LoBuglio, and
J McCracken, and
R Pugh
July 2001,
Urologic oncology,
